Johns Hopkins HIV Guide
Fenofibrate
INDICATIONS
FDA
FDA
- Hypertriglyceridemia
- Hypercholesterolemia or mixed dyslipidemia
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- ART-associated hypertriglyceridemia
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 21, 2016
Citation
Smith, Janessa M, and Paul A Pham. "Fenofibrate." Johns Hopkins HIV Guide, 2016. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545072/all/Fenofibrate.
Smith JM, Pham PA. Fenofibrate. Johns Hopkins HIV Guide. 2016. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545072/all/Fenofibrate. Accessed December 1, 2023.
Smith, J. M., & Pham, P. A. (2016). Fenofibrate. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545072/all/Fenofibrate
Smith JM, Pham PA. Fenofibrate [Internet]. In: Johns Hopkins HIV Guide. ; 2016. [cited 2023 December 01]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545072/all/Fenofibrate.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fenofibrate
ID - 545072
A1 - Smith,Janessa,PharmD, BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2016/10/21/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545072/all/Fenofibrate
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
